Home/Filings/4/0001104659-21-081983
4//SEC Filing

He Wei-Wu 4

Accession 0001104659-21-081983

CIK 0000895051other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:01 PM ET

Size

5.7 KB

Accession

0001104659-21-081983

Insider Transaction Report

Form 4
Period: 2021-06-15
He Wei-Wu
Director
Transactions
  • Award

    Stock Options (Right to Buy)

    2021-06-15+4,000,0004,000,000 total
    Exercise: $1.73Exp: 2031-04-27Common Stock (4,000,000 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the Board of Directors on April 27, 2021, subject to stockholder approval of the option grant. The Company's stockholders approved the option grant on June 15, 2021.
  • [F2]The stock options will vest as follows: 25 percent on each of the first, second, third and fourth anniversaries of the date of grant.

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1
  • filerCIK 0001542073

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:01 PM ET
Size
5.7 KB